8-60862256-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017780.4(CHD7):c.7891C>T(p.Arg2631*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017780.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
CHARGE syndrome Pathogenic:4
The observed stop gained variant c.7891C>T(p.Arg2631Ter) in the CHD7 gene has been reported previously in multiple individuals affected with clinical features of CHARGE syndrome (Bartels CF, et al., 2010; Lim EC, et al., 2015). This variant is absent in the gnomAD Exomes. It is submitted to ClinVar as Pathogenic by multiple submitters. Computational evidence (MutationTaster - Disease causing) predicts damaging effect on protein structure and function for this variant. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CHD7 are known to be pathogenic (PMID: 22461308, 25077900). This variant has been observed in individual(s) with clinical features of CHARGE syndrome (PMID: 26666243, 21158681). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg2631*) in the CHD7 gene. It is expected to result in an absent or disrupted protein product. -
- -
- -
not provided Pathogenic:3
The CHD7 c.7891C>T; p.Arg2631Ter variant (rs587783457) is reported in the medical literature in several individuals with CHARGE syndrome (Bartels 2010). The variant is reported in the ClinVar database (Variation ID: 158320) and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Considering available information, this variant is classified as pathogenic. References: Bartels CF et al. Mutations in the CHD7 gene: the experience of a commercial laboratory. Genet Test Mol Biomarkers. 2010 Dec;14(6):881-91. -
CHD7: PVS1, PM2, PS2:Moderate, PS4:Moderate -
Has also been reported in a patient with features of congenital hypogonadotropic hypogonadism (PMID: 37108593); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26666243, 25525159, 32804436, 37108593, 21158681) -
CHD7-related disorder Pathogenic:1
The CHD7 c.7891C>T variant is predicted to result in premature protein termination (p.Arg2631*). This variant has been reported in multiple individuals with CHARGE syndrome (Bartels et al. 2010. PubMed ID: 21158681; Wei et al. 2020. PubMed ID: 32804436). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in CHD7 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Hypogonadotropic hypogonadism 5 with or without anosmia Pathogenic:1
Variant summary: CHD7 c.7891C>T (p.Arg2631X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 244614 control chromosomes. c.7891C>T has been reported in the literature as heterozygous genotype in multiple individuals affected with clinical features of CHARGE syndrome (Bartels_2010, Lim_2015). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21158681, 26666243). ClinVar contains an entry for this variant (Variation ID: 158320). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at